MRIGlobal's multi-disciplinary team enhances health and security worldwide.
MRIGlobal's Global Engagement Program delivers collaborative solutions that meet the evolving and interwoven challenges to worldwide health and security. Over the last 10 years, MRIGlobal has designed and executed programs in 19 countries throughout Asia, the Middle East, East Africa, and Europe.
Our Global Engagement Program stands ready to design and execute programs that enhance health and security.
We focus to improve laboratory capacity, disease surveillance, response, and prediction. We build cooperative research partnerships and provide ongoing mentoring for sustainable and programmatic success. Such research partnerships open avenues for new research directions and foster new collaborative opportunities for U.S. and foreign scientists.
Our Global Engagement Program experts have extensive experience in microbiology, molecular biology, biotechnology, biosafety and biosecurity (BS&S), human and veterinary medicine, and facility engineering. They include certified professionals in project management, biosafety, public health, and security.
Our capabilities also include providing viral diagnostics, immunology and core services to the National Institutes of Health / National Institute of Allergy and Infectious Diseases (NIAIDs) Integrated Research Facility (IRF) at Ft. Detrick.
As a trusted life science organization, we take pride in being responsive to our clients and listening to and understanding their needs. As new challenges and threats to global health security continue to evolve, MRIGlobal's
Global Engagement Program is dedicated to meeting those challenges through innovative cross-disciplinary solutions and cutting-edge science.
• Dr. Gene Olinger was a distinguished speaker at the Infectious Diseases World Summit July 8-10 in Boston, MA. Dr.
Olinger spoke at the day 1 plenary session. The session topic was "Vaccines for the Developing World," including the special topic "Lessons Learned from the 2014 Ebola Outbreak."
Advancing Biosurveillence for Biodefense in Kazakhstan (PDF)
Ebola Treatments Caught in Limbo
(Nature, July 2014)
article in the journal Nature explores how logistics and lack of funding keeps experimental drugs and vaccines from being used in the Africa outbreak.
MRIGlobal researcher Dr. Gene Olinger is among the scientists quoted in the article. Dr. Olinger also contributed to two recent articles from the Proceedings of the National Academy of Sciences:
New High-Tech Laboratory in Kazakhstan to Fight Plague Outbreaks
(National Geographic, September 2013)
article in National Geographic magazine describes a new biosecurity laboratory, the Central Reference Laboratory, which will open in 2015 and offer high-security lab space for scientists to study dangerous diseases and provide early warning of potential outbreaks. MRIGlobal has supported this effort since its inception.